Journal of Innovative Optical Health Sciences, Volume. 5, Issue 2, 1250007(2012)
COMPARISON OF AMINOLEVULINIC ACID AND ITS METHYL ESTER MEDIATED PHOTOCYTOTOXICITY ON HUMAN NASOPHARYNGEAL CARCINOMA CELLS
[1] [1] A. T. Chan, "Nasopharyngeal carcinoma," Ann. Oncol. Suppl 7(vii), 308-312 (2010).
[2] [2] J. Guigay, "Advances in nasopharyngeal carcinoma," Curr. Opin. Oncol. 20(3), 264-269 (2008).
[3] [3] Z. Huang, "A review of progress in clinical photodynamic therapy," Technol. Cancer Res. Treat. 4(3), 283-293 (2005).
[4] [4] M. A. Wildeman, H. J. Nyst, B. Karakullukcu, B. I. Tan, "Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer," Head Neck Oncol. 1(40), 1-6 (2009).
[5] [5] P. Agostinis, K. Berg, K. A. Cengel, T. H. Foster, A. W. Girotti, S. O. Gollnick, S. M. Hahn, M. R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowis, J. Piett, B. C. Wilson, J. Golab, "Photodynamic therapy of cancer: an update," CA Cancer J. Clin. 61(4), 250-281 (2011).
[6] [6] Z. Q. Sun, G. Y. Luo, "Photodynamic therapy for recurrent nasopharyngeal carcinoma after radiotherapy (An analysis of 191 cases)," Chin. J. Laser Med. Surg. 5, 134-136 (1996) (in Chinese).
[7] [7] M. C. Tong, C. A. van Hasselt, J. K. Woo, "Preliminary results of photodynamic therapy for recurrent nasopharyngeal carcinoma," Eur. Arch. Otorhinolaryngol. 253(3), 189-192 (1996).
[8] [8] L. Li, R. Luo, W. Liao, M. Zhang, Y. Luo, J. Miao, "Clinical study of Photofrin photodynamic therapy for the treatment of relapse nasopharyngeal carcinoma," Photodiag. Photodyn. Ther. 3(4), 266-271 (2006).
[9] [9] J. Bedwell, A. J. MacRobert, D. Phillips, S. G. Bown, "Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model," Br. J. Cancer 65(6), 818-824 (1992).
[10] [10] C. S. Betz, J. P. Lai, W. Xiang, P. Janda, P. Heinrich, H. Stepp, R. Baumgartner and A. Leunig, "In vitro photodynamic therapy of nasopharyngeal carcinoma using 5-aminolevulinic acid," Photochem. Photobiol. Sci. 1(5), 315-319 (2002).
[11] [11] V. Manivasager, P. W. Heng, J. Hao, W. Zheng, K. C. Soo, M. Olivo, "Macro-microscopic fluorescence imaging of human NPC xenografts in a murine model using topical vs intravenous administration of 5-aminolevulinic acid," Int. J. Oncol. 21(5), 1003-1007 (2002).
[12] [12] V. Manivasager, K. K. Yee, P. W. Heng, K. C. Soo, M. Olivo, "A study comparing endogenous protoporphyrin IX induced by 5-ALA and ALA-methyl ester with exogenous PpIX and PpIX dimethyl ester in photodynamic diagnosis of human nasopharyngeal carcinoma xenografts," Int. J. Oncol. 29(4), 997-1002 (2002).
[13] [13] N. Fotinos, M. A. Campo, F. Popowycz, R. Gurny, N. Lange, "5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives," Photochem. Photobiol. 82(4), 994-1015 (2006).
[14] [14] S. B. Brown, "The role of light in the treatment of non-melanoma skin cancer using methyl aminolevulinate," J.Dermatolog.Treat. 14(Suppl. 3), 11-14 (2003).
[15] [15] J. A. Witjes, J. Douglass, "The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer," Nat. Clin. Pract. Urol. 4(10), 542-549 (2007).
[16] [16] D. P. Huang, J. H. Ho, Y. F. Poon, E. C. Chew, D. Saw, M. Lui, C. L. Li, L. S. Mak, S. H. Lai, W. H. Lau, "Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx," Int. J. Cancer 26(2), 127-132 (1980).
[17] [17] Z. Sizhong, G. Xiukung, Z. Yi, "Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma," Int. J. Cancer 31(5), 587-590 (1983).
[18] [18] E. A. Hryhorenko, K. Rittenhouse-Diakun, N. S. Harvey, J. Morgan, C. C. Stewart and A. R. Oseroff, "Characterization of endogenous protoporphyrin IX induced by delta-aminolevulinic acid in resting and activated peripheral blood lymphocytes by four-color flow cytometry," Photochem. Photobiol. 67(5), 565-572 (1998).
[19] [19] R. W. K. Wu, E. S. M. Chu, C. M. N. Yow, J. Y. Chen, "Photodynamic effects on nasopharyngeal carcinoma (NPC) cells with 5-aminolevulinic acid or its hexyl ester," Cancer Lett. 242(1), 112-119 (2006).
[20] [20] C. M. N. Yow, J. Y. Chen, N. K. Mam, N. H. Cheung, A. W. Leung, "Cellular uptake, subcellular, localization and photodamaging effect of temoporfin (mTHPC) in nasopharyngeal carcinoma cells: comparison with hematoporphyrin derivative (HPD)," Cancer Lett. 157(2), 123-131 (2000).
[21] [21] P. L. Olive, J. P. Banath, "Induction and rejoining of radiation-induced DNA single-strand breaks: "tail moment" as a function of position in the cell cycle," Mutation Res. 294(3), 275-283 (1993).
[22] [22] S. L. Gibson, J. J. Havens, T. H. Foster, R. Hilf, "Time-dependent intracellular accumulation of delta-aminolevulinic acid, induction of porphyrin synthesis and subsequent phototoxicity," Photochem. Photobiol. 65(3), 416-421 (1997).
[23] [23] J. M. Gaullier, K. Berg, Q. Peng, H. Anholt, P. K. Selbo, L. W. Ma, J. Moan, "Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture," Cancer Res. 57(8), 1481-1486 (1997).
[24] [24] K. P. Uberriegler, E. Banieghbal, B. Krammer, "Subcellular damage kinetics within co-cultivated WI38 and VA13-transformed WI38 human fibroblasts following 5-aminolevulinic acid-induced protoporphyrin IX formation," Photochem. Photobiol. 62(6), 1052-1057 (1995).
[25] [25] B. Li, Z. Chen, L. Liu, Z. Huang, Z. Huang, S. Xie, "Differences in sensitivity to HMME-mediated photodynamic therapy between EBVt C666-1 and EBV- CNE2 cells," Photodiagnosis Photodyn. Ther. 7(3), 204-209 (2010).
[26] [26] C. M. Yow, C. K. Wong, Z. Huang, R. J. Ho, "Study of the efficacy and mechanism of ALA-mediated photodynamic therapy on human hepatocellular carcinoma cell," Liver Int. 27(2), 201-208 (2007).
[27] [27] R. W. Wu, C. M. Yow, C. K. Wong, Y. H. Lam, "Photodynamic therapy (PDT) — Initiation of apoptosis via activation of stress-activated p38 MAPK and JNK signal pathway in H460 cell lines," Photodiagnosis Photodyn. Ther. 8(3), 254-263 (2011).
[28] [28] J. M. Gaullier, M. Gèze, R. Santus, T. Sa e Melo, J. C. Mazière, M. Bazin, P. Morlière, L. Dubertret, "Subcellular localization of and photosensitization by protoporphyrin IXhuman keratinocytes and fibroblasts cultivated with 5-aminolevulinic acid," Photochem. Photobiol. 62(1), 114-122 (1995).
[29] [29] B. C. Wilson, M. Olivo, G. Singh, "Subcellular localization of Photofrin, aminolevulinic acid, photodynamic cross-resistance in vitro in radiationinduced fibrosarcoma cells sensitive or resistant to photofrin-mediated photodynamic therapy," Photochem. Photobiol. 65(1), 166-176 (1997).
[30] [30] L. Henderson, A. Wolfreys, J. Fedyk, C. Bourner, S. Windebank, "The ability of the Comet assay to discriminate between genotoxins, cytotoxins," Mutagenesis 13(1), 89-94 (1998).
[31] [31] E. S. Chu, R. W. Wu, C. M. Yow, T. K. Wong, J. Y. Chen, "The cytotoxic, genotoxic potential of 5-aminolevulinic acid on lymphocytes: A comet assay study," Cancer Chemother. Pharmacol. 58(3), 408-414 (2006).
[32] [32] R. Musiol, M. Serda, J. Polanski, "Prodrugs in photodynamic anticancer therapy," Curr. Pharm. Des. 17(32), 3548-3559 (2011).
Get Citation
Copy Citation Text
CHRISTINE M. N. YOW, RICKY W. K. WU, ZHENG HUANG. COMPARISON OF AMINOLEVULINIC ACID AND ITS METHYL ESTER MEDIATED PHOTOCYTOTOXICITY ON HUMAN NASOPHARYNGEAL CARCINOMA CELLS[J]. Journal of Innovative Optical Health Sciences, 2012, 5(2): 1250007
Received: Mar. 6, 2012
Accepted: --
Published Online: Jan. 10, 2019
The Author Email: N. YOW CHRISTINE M. (htcyow@inet.polyu.edu.hk)